Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD476 (Lialda) in mild to moderate ulcerative colitis
NCT00548574Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Takeda. Started Dec 2003; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00548574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548574.